{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:06:54Z","timestamp":1787317614772,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,12,18]],"date-time":"2008-12-18T00:00:00Z","timestamp":1229558400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s12185-008-0214-0","type":"journal-article","created":{"date-parts":[[2008,12,17]],"date-time":"2008-12-17T03:53:43Z","timestamp":1229486023000},"page":"80-85","source":"Crossref","is-referenced-by-count":7,"title":["A case of age-related EBV-associated B-cell lymphoproliferative disorder metachronously showing two distinct morphologic appearances, one of a polymorphic disease resembling classical Hodgkin lymphoma, and the other of a large-cell lymphoma"],"prefix":"10.1007","volume":"89","author":[{"given":"Tadashi","family":"Murase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Hoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Kuramochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,18]]},"reference":[{"key":"214_CR1","first-page":"255","volume-title":"Tumours of haematopoietic and lymphoid tissues","author":"B Borisch","year":"2001","unstructured":"Borisch B, Raphael M, Swerdlow SH, Jaffe ES. Immunodeficiency associated lymphoproliferative disorders. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 255\u201371."},{"key":"214_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","volume":"27","author":"T Oyama","year":"2003","unstructured":"Oyama T, Ichimura K, Suzuki R, et al. Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol. 2003;27:16\u201326. doi:\n                    10.1097\/00000478-200301000-00003\n                    \n                  .","journal-title":"Am J Surg Pathol"},{"key":"214_CR3","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1158\/1078-0432.CCR-06-2823","volume":"13","author":"T Oyama","year":"2007","unstructured":"Oyama T, Yamamoto K, Asano N, et al. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res. 2007;13:5124\u201332. doi:\n                    10.1158\/1078-0432.CCR-06-2823\n                    \n                  .","journal-title":"Clin Cancer Res"},{"key":"214_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/1521-4141(200002)30:2<458::AID-IMMU458>3.0.CO;2-5","volume":"30","author":"H Laumen","year":"2000","unstructured":"Laumen H, Nielsen PJ, Wirth T. The Bob.1\/OBF.1 co-activtor is essential for octamer-dependent transcription in B cells. Eur J Immunol. 2000;30:458\u201369. doi:10.1002\/1521-4141(200002)30:2<458::AID-IMMU458>3.0.CO;2-5.","journal-title":"Eur J Immunol"},{"key":"214_CR5","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1182\/blood.V97.2.496","volume":"97","author":"H Stein","year":"2001","unstructured":"Stein H, Marafioti T, Foss HD, et al. Down-regulation of Bob.1\/OBF and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood. 2001;97:496\u2013501. doi:\n                    10.1182\/blood.V97.2.496\n                    \n                  .","journal-title":"Blood"},{"key":"214_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1056\/NEJM197903013000902","volume":"300","author":"JG Krikorian","year":"1979","unstructured":"Krikorian JG, Burke JS, Rosenberg SA, Kaplan HS. Occurrence of non-Hodgkin\u2019s lymphoma after therapy for Hodgkin\u2019s disease. N Engl J Med. 1979;300:452\u20138.","journal-title":"N Engl J Med"},{"key":"214_CR7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archinte.1983.00350030055011","volume":"143","author":"JO Armitage","year":"1983","unstructured":"Armitage JO, Dick FR, Goeken JA, Foucar MK, Gingrich RD. Second lymphoid malignant neoplasms occurring in patients treated for Hodgkin\u2019s disease. Arch Intern Med. 1983;143:445\u201350. doi:\n                    10.1001\/archinte.143.3.445\n                    \n                  .","journal-title":"Arch Intern Med"},{"key":"214_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1056\/NEJM198801143180203","volume":"318","author":"MA Tucker","year":"1988","unstructured":"Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA. Risk of second cancers after treatment for Hodgkin\u2019s disease. N Engl J Med. 1988;318:76\u201381.","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"214_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/annonc\/2.suppl_2.83","volume":"2","author":"MH Bennett","year":"1991","unstructured":"Bennett MH, MacLennan KA, Vaughan Hudson G, Vaughan Hudson B. Non-Hodgkin\u2019s lymphoma arising in patients treated for Hodgkin\u2019s disease in the BNLI: a 20-year experience. Ann Oncol. 1991;2(suppl 2):83\u201392.","journal-title":"Ann Oncol"},{"key":"214_CR10","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1097\/00000478-199209000-00007","volume":"16","author":"A Zarate-Osorno","year":"1992","unstructured":"Zarate-Osorno A, Medeiros LJ, Longo DL, Jaffe ES. Non-Hodgkin\u2019s lymphomas arising in patients successfully treated for Hodgkin\u2019s disease. Am J Surg Pathol. 1992;16:885\u201395. doi:\n                    10.1097\/00000478-199209000-00007\n                    \n                  .","journal-title":"Am J Surg Pathol"},{"key":"214_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1200\/JCO.1994.12.2.312","volume":"12","author":"FE Leeuwen van","year":"1994","unstructured":"van Leeuwen FE, Klokman WJ, Hagenbeek A, et al. Second cancer risk following Hodgkin\u2019s disease: a 20 year follow-up study. J Clin Oncol. 1994;12:312\u201325.","journal-title":"J Clin Oncol"},{"key":"214_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1200\/JCO.2000.18.3.487","volume":"18","author":"FE Leeuwen van","year":"2000","unstructured":"van Leeuwen FE, Klokman WJ, van\u2019t Veer MB, et al. Long-term risk of second malignancy in survivors of Hodgkin\u2019s disease treated during adolescence or young adulthood. J Clin Oncol. 2000;18:487\u201397.","journal-title":"J Clin Oncol"},{"key":"214_CR13","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1200\/JCO.2001.19.7.2026","volume":"19","author":"U Rueffer","year":"2001","unstructured":"Rueffer U, Josting A, Franklin J, et al. Non-Hodgkin\u2019s lymphoma after primary Hodgkin\u2019s disease in the German Hodgkin\u2019s lymphoma study group: incidence, treatment and prognosis. J Clin Oncol. 2001;19:2026\u201332.","journal-title":"J Clin Oncol"},{"key":"214_CR14","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1200\/JCO.2002.09.038","volume":"20","author":"GM Dores","year":"2002","unstructured":"Dores GM, Metayer C, Curtis RE, et al. Second malignant neoplasms among long-term survivors of Hodgkin\u2019s disease: a population-based evaluation over 25 years. J Clin Oncol. 2002;20:3484\u201394. doi:\n                    10.1200\/JCO.2002.09.038\n                    \n                  .","journal-title":"J Clin Oncol"},{"issue":"2","key":"214_CR15","first-page":"252","volume":"27","author":"T Murase","year":"1986","unstructured":"Murase T, Suzuki M, Toyama K. Complete remission obtained by sequential chemotherapy of l-asparaginase and continuous infusion of bleomycin (ABLE protocol) in a case of refractory diffuse large cell lymphoma of a paranasal origin. Rinsho Ketsueki. 1986;27(2):252\u20136.","journal-title":"Rinsho Ketsueki"},{"key":"214_CR16","first-page":"440","volume":"15","author":"T Murase","year":"1987","unstructured":"Murase T, Kondo M. Infusional bleomycin with l-asparaginase and\/or BCNU as a salvage therapy for refractory lymphoid malignancies. Exp Hematol. 1987;15:440.","journal-title":"Exp Hematol"},{"key":"214_CR17","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/j.1440-1827.2007.02158.x","volume":"57","author":"E Shiozawa","year":"2007","unstructured":"Shiozawa E, Saito B, Yamochi-Onizuka T, et al. Senile EBV-associated B-cell lymphoproliferative disorder of indolent clinical phenotype with recurrence as aggressive lymphoma. Pathol Int. 2007;57:668\u201393. doi:\n                    10.1111\/j.1440-1827.2007.02158.x\n                    \n                  .","journal-title":"Pathol Int"},{"key":"214_CR18","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1182\/blood-2004-09-3759","volume":"106","author":"RF Jarrett","year":"2005","unstructured":"Jarrett RF, Stark GL, White J, et al. Impact of tumor Epstein\u2013Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma:a population-based study. Blood. 2005;106:2444\u201351. doi:\n                    10.1182\/blood-2004-09-3759\n                    \n                  .","journal-title":"Blood"},{"key":"214_CR19","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<510::AID-IJC2>3.0.CO;2-X","volume":"71","author":"RM Amini","year":"1997","unstructured":"Amini RM, Emblad G, Sundstroem C, Glimelius B. Patients suffering from both Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients. Int J Cancer. 1997;71:510\u20136. doi: 10.1002\/(SICI)1097-0215(19970516)71:4<510::AID-IJC2>3.0.CO;2-X.","journal-title":"Int J Cancer"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0214-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-008-0214-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0214-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0214-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:01:22Z","timestamp":1559437282000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-008-0214-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,18]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["214"],"URL":"https:\/\/doi.org\/10.1007\/s12185-008-0214-0","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,18]]}}}